Matthew Holt

(Mr. Matthew Holt)

Positions

Position Company Period
Independent Director Bellerophon Therapeutics Inc None -
Matthew Holt's trades of Bellerophon Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2015-02-23 2015-02-19
B Purchase
1,070,166 +28.2%
12.00
USD 12,841,992 		1,070,166 +28.2% 12.00 USD 12,841,992
// ... existing code ... // ... rest of the file ...